Tema Oncology ETF
$37.28-1.05%($-0.40)
TickerSpark Score
Not enough financial coverage to compute a composite score for CANC. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Momentum100
52-Week Range84% of range
Low $23.43
Current $37.28
High $39.95
Companytemaetfs.com/canc
The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.
- IPO
- 2023
- HQ
- New York, NY, US
Price Chart
+54.18% · this period
Valuation
- Market Cap
- $118.27M
- Div Yield
- 0.05%
Performance & Tape
- 52W High
- $39.95
- 52W Low
- $23.43
- 50D MA
- $37.24
- 200D MA
- $33.54
- Beta
- 0.76
- Avg Volume
- 24.68K
Get TickerSpark's AI analysis on CANC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CANC Coverage
We haven't published any research on CANC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CANC Report →Similar Companies
MINV+0.82%
Matthews Asia Innovators Active ETF MINV
$51.49
OVLH+0.51%
Overlay Shares Hedged Large Cap Equity ETF
$41.67
SPBC-0.71%
Simplify US Equity PLUS Bitcoin Strategy ETF
$47.62
KARS-0.06%
KraneShares Electric Vehicles & Future Mobility Index ETF
$35.00
PSMD+0.35%
Pacer Swan SOS Moderate (January) ETF
$33.98
BATT+0.59%
Amplify Lithium & Battery Technology ETF
$16.48
MAVF+1.02%
Matrix Advisors Value ETF
$132.10
CVMC+1.40%
Calvert US Mid-Cap Core Responsible Index ETF
$70.27